241 filings
Page 6 of 13
8-K
rus4494s zz
14 May 20
Regulation FD Disclosure
9:11am
8-K
7lykn34x
11 May 20
Regulation FD Disclosure
9:12am
8-K
3uqb35cvsexvjf
28 Apr 20
CRISPR Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results
4:50pm
DEFA14A
jgulen5ajlzw
24 Apr 20
Additional proxy soliciting materials
4:11pm
D/A
li3n u9zg
10 Apr 20
$1M in equity, sold $1M, 1 investor
11:01am
D
4lpygxzekc
9 Apr 20
$1M in equity, sold $1M, 1 investor
4:42pm
8-K
w46 oxopw662
31 Mar 20
Other Events
4:08pm
8-K
ryjuxp5 3ln9o091
26 Feb 20
CRISPR Therapeutics Proposes Changes to the Board of Directors
4:10pm
8-K
t4qy0c
12 Feb 20
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:05pm
8-K
3l0d440
29 Jan 20
Departure of Directors or Certain Officers
4:16pm
8-K
edsu963dd8udrwi
27 Dec 19
Termination of a Material Definitive Agreement
4:06pm
8-K
tbfdcenj1csb89vh
16 Dec 19
Entry into a Material Definitive Agreement
7:01am
8-K
bomprvo z7f
22 Nov 19
Crispr Therapeutics Announces Proposed Public Offering of Common Shares
4:02pm
424B5
ykljas
21 Nov 19
Prospectus supplement for primary offering
4:12pm
424B5
kehfjgyv
19 Nov 19
Prospectus supplement for primary offering
4:27pm
8-K
sgdm5h 49r2p
19 Nov 19
Regulation FD Disclosure
8:21am